Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Mesoporous polydopamine delivering 8-gingerol for the target and synergistic treatment to the spinal cord injury

Fig. 6

A In vivo fluorescence imaging of rats 36 h after Cy5.5-labelled M-PDA injection via tail vein. B In vitro fluorescence imaging of M-PDA in the spinal cord and brain. C In vitro fluorescence imaging of M-PDA in the major organs of the rat. D Quantification of the fluorescence signal intensity of M-PDA at the site of SCI. E Quantification of the fluorescence signal intensity of M-PDA in the isolated SCI center and brain of rats. F Quantification of the fluorescence signal intensity of M-PDA in major organs of rats. G Fluorescence images of spinal cord tissue in SCI rats after tail vein injection of Cy5.5-labelled M-PDA (Scale bar = 200 μm)

Back to article page